Shakti Press Board to Consider Fresh Fund Raising on October 26

Shakti Press Limited will consider fresh fund-raising options at its board meeting on October 26, 2026, following a ₹49.28 crore rights issue in 2026 and the allotment of 94.75 lakh convertible warrants earlier in the financial year. The meeting is material because it may determine the company’s next route for raising capital.

What will Shakti Press consider at its October 26 board meeting?

Shakti Press has informed the stock exchange that its board will meet on October 26, 2026, to consider a proposal for raising funds through the issue of instruments or securities. The options identified in the disclosure include a qualified institutional placement, private placement, preferential issue and rights issue, as well as other permissible modes or a combination of such routes.

The company has not disclosed a proposed issue size, issue price, investor category, use of proceeds or the final instrument to be issued. The board meeting is therefore a consideration of fund-raising alternatives, rather than a confirmed capital-raising transaction. Any eventual proposal may require approvals from shareholders and regulatory authorities, depending on the structure selected.

The trading window was closed from October 24 in connection with the board meeting. This follows the company’s disclosure under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, which requires listed companies to report material board decisions and events to exchanges.

How did Shakti Press raise capital during FY26?

Shakti Press strengthened its capital base during FY26 through a preferential issue of convertible warrants and a rights issue. BSE Limited gave in-principle approval on January 2, 2026, for the preferential issue of 94.75 lakh convertible warrants at a price of not less than ₹27.25 per warrant.

The warrants were allotted in tranches on January 9 and January 17, 2026. The supplied disclosures do not state the total amount received from the warrant issue, conversion status, or the number of equity shares issued upon conversion. Investors should distinguish the warrant issue from a direct equity allotment, as warrants are convertible instruments subject to their applicable terms.

The board also approved raising funds through a rights issue on January 6, 2026. The rights issue comprised 2.46 crore equity shares with a face value of ₹10 each, offered at ₹20 per share. It had an aggregate issue size of ₹49.28 crore and was listed on the BSE.

What were the terms and timeline of the 2026 rights issue?

Shakti Press fixed April 29, 2026, as the record date to determine shareholders eligible for the rights issue. Eligible shareholders received rights in the ratio of seven equity shares for every one equity share held, according to the supplied issue details.

The issue opened on May 7, 2026, and closed on June 2, 2026. The disclosures also state a deemed allotment date of May 20, 2026, expected credit of shares to demat accounts on May 21, and expected BSE listing on May 22. These dates are presented as disclosed in the source material.

A rights issue gives existing shareholders an opportunity to subscribe to additional shares in proportion to their holdings. For Shakti Press, the ₹20 issue price and 7:1 entitlement ratio were the key commercial terms made available to shareholders. The supplied information does not specify the stated use of the rights-issue proceeds.

Why is the latest fund-raising discussion significant for investors?

The October meeting is significant because Shakti Press has already undertaken multiple capital-market actions during FY26. A new proposal could affect the company’s capital structure, depending on whether the board chooses equity shares, convertible securities, institutional placement, a preferential allotment or another route permitted under applicable regulations.

The potential impact on shareholders cannot be quantified from the present disclosure because the company has not announced an amount, pricing, number of securities or identity of proposed allottees. These details will be central to assessing any dilution, subscription terms and the potential role of new or existing investors.

The company’s recent revenue disclosure also provides context for the capital discussions. Shakti Press reported FY26 revenue of ₹7,829 lakh, described as a fivefold increase linked to its agri division push. That figure equals ₹78.29 crore when expressed in crores. The supplied material does not provide profit, cash-flow or debt figures that would establish how any future funds may be deployed.

How has Shakti Press approached fund raising in recent disclosures?

Shakti Press has evaluated more than one capital-raising route over the past year. At its December 12, 2025 meeting, the board considered available fund-raising options, including QIP, private placement, preferential issue and rights issue, but decided not to pursue further fund raising in the near future at that time.

The company subsequently approved the rights issue in January 2026 and completed warrant allotments during the same month. This sequence shows that board-level evaluations did not rule out later fund raising if requirements changed. However, the current October 26 intimation itself does not state why the company is again considering capital raising.

Shareholders also approved FY26 financial statements and ratified key related-party transactions at Shakti Press’s 33rd annual general meeting on August 21, 2026. Separately, disclosures in August 2025 referred to a proposed preferential allotment of equity shares on a private-placement basis and the proposed appointment of Subrat Banerjee as executive director.

Conclusion

Shakti Press is returning to the boardroom on October 26 to evaluate new fund-raising options after a ₹49.28 crore rights issue and a 94.75 lakh-warrant preferential issue during FY26. The available disclosure establishes the funding routes under review, but it does not confirm a transaction or provide the amount, pricing, instrument or proposed use of proceeds.

Investors should watch for the board-meeting outcome, particularly any decision on the selected route, number of securities, issue price, proposed allottees and required approvals. Those details will clarify whether the proposal changes the company’s equity base or creates future dilution through convertible instruments.